Be Prepared to Dispense Alternatives to Usual COVID-19 Meds
Shortages of tocilizumab (Actemra) mean you'll see more orders for other COVID-19 treatments.
Tocilizumab has been the go-to add-on to steroids (dexamethasone, etc) for COVID-19. It's because this "IL-6 inhibitor" has the strongest evidence for reducing mortality.
But tocilizumab supplies are low. And it may need to be reserved for other uses where tocilizumab is the only treatment.